NCT06103487View on ClinicalTrials.gov

Long Term Follow-Up for RGX-111

Enrolling by invitationOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Mucopolysaccharidosis I
Interventions
GENETIC

No Intervention

Observational study

Trial Locations (2)

92868

Children's Hospital of Orange County, Orange

90035-903

Hospital de Clinicas de Porto Alegre, Porto Alegre

All Listed Sponsors
lead

REGENXBIO Inc.

INDUSTRY

NCT06103487 - Long Term Follow-Up for RGX-111 | Biotech Hunter | Biotech Hunter